Hypothesis: Senescent Cells Act as Temporal Switches in Tissue Repair

We propose that senescent cells are not static signaling sources but dynamic negotiators whose SASP composition shifts over time to first promote repair then enforce a proliferative brake. In young tissue, early SASP (rich in PDGF‑AA, CCN1/2, IL‑10) recruits macrophages and stimulates fibroblast migration, facilitating closure. As repair progresses, a feedback loop involving TGF‑β and Notch signaling induces a senescent sub‑population that switches to a brakes‑on SASP (high IL‑6, IL‑8, MMPs, FasL) that limits further proliferation and invites immune clearance. In aged tissue, the transition is blunted: epigenetic constraints maintain the pro‑regenerative SASP while impairing the brakes‑on switch, leading to prolonged low‑grade inflammation and failed resolution. This model predicts that manipulating the timing of the SASP switch—e.g., transiently boosting Notch activity in senescent fibroblasts—will restore the brakes‑on phase and improve healing without increasing senescent cell burden.

Mechanistic Reasoning

1. SASP heterogeneity – Single‑cell transcriptomics reveal G2‑arrested senescent fibroblasts secrete more IL‑6 and are senolytic‑sensitive 7. We hypothesize that G2‑arrested cells represent the brakes‑on sub‑population, whereas G1‑arrested cells drive the early pro‑regenerative profile.
2. Epigenetic uncoupling – SASP can be epigenetically uncoupled from cell cycle arrest 8, allowing the same arrested cell to toggle secretomes via histone acetylation at NF‑κB‑dependent promoters. In youth, rapid HDAC‑mediated deacetylation after PDGF‑AA signaling silences pro‑regenerative genes and permits Notch‑driven IL‑6/FasL expression. Aging reduces HDAC activity, locking cells in the early SASP.
3. Immune feedback – Macrophages recruited by early SASP release TGF‑β, which activates Smad3 in senescent fibroblasts, prompting the brakes‑on switch 2. In aged wounds, macrophage senescence diminishes TGF‑β output, breaking the feedback.

Testable Predictions

• Prediction 1: In young mouse wound models, single‑cell RNA‑seq of senescent fibroblasts at 24 h will show a G1‑enriched cluster expressing PDGF‑AA, CCN1/2; at 72 h a G2‑enriched cluster will up‑regulate IL‑6, IL‑8, MMP9, FasL. This shift will be absent in aged mice.
• Prediction 2: Pharmacological inhibition of HDAC6 in young wounds will prolong the early SASP cluster and delay the brakes‑on transition, mimicking the aged phenotype.
• Prediction 3: Activating Notch signaling in senescent fibroblasts of aged mice (via Jagged1‑Fc) will induce the brakes‑on SASP and accelerate closure, without altering senescent cell numbers measured by p16^INK4a^ staining.
• Prediction 4: Blocking TGF‑β signaling in young wounds will prevent the brakes‑on switch, leading to persistent PDGF‑AA secretion and hyperproliferation, measurable by increased Ki‑67^+^ fibroblasts and aberrant collagen deposition.

Falsifiability

If temporal SASP switching does not occur—i.e., senescent fibroblasts maintain a static secretome irrespective of repair stage—or if manipulating Notch/HDAC fails to alter healing outcomes as predicted, the hypothesis is refuted.